VICTOR KRASNYKH to Tumor Cells, Cultured
This is a "connection" page, showing publications VICTOR KRASNYKH has written about Tumor Cells, Cultured.
Connection Strength
0.196
-
Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol. 2003 Nov; 77(21):11367-77.
Score: 0.033
-
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res. 1999 Sep; 5(9):2571-9.
Score: 0.025
-
Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Gene Ther. 2004 Dec; 11(23):1694-702.
Score: 0.009
-
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology. 2003 Oct; 125(4):1203-18.
Score: 0.008
-
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology. 2003 May 10; 309(2):282-93.
Score: 0.008
-
The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer. 2003 May 06; 88(9):1411-6.
Score: 0.008
-
Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res. 2003 Mar 15; 63(6):1262-9.
Score: 0.008
-
Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement. J Gastrointest Surg. 2003 Mar-Apr; 7(3):364-71.
Score: 0.008
-
Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein. J Hepatol. 2002 Nov; 37(5):660-8.
Score: 0.008
-
The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer. 2002 Sep; 38(14):1917-26.
Score: 0.008
-
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res. 2002 Aug 01; 62(15):4273-81.
Score: 0.008
-
Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology. 2002 May; 223(2):417-25.
Score: 0.007
-
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin Cancer Res. 2002 Jan; 8(1):275-80.
Score: 0.007
-
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther. 2001 Jul; 8(13):969-76.
Score: 0.007
-
Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells. Jpn J Cancer Res. 2001 Mar; 92(3):321-7.
Score: 0.007
-
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin Cancer Res. 2001 Jan; 7(1):120-6.
Score: 0.007
-
Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid. Hum Gene Ther. 2000 Aug 10; 11(12):1657-69.
Score: 0.007
-
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol. 2000 Aug; 74(15):6875-84.
Score: 0.007
-
An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. Gynecol Oncol. 1999 Aug; 74(2):227-34.
Score: 0.006
-
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998 Dec; 72(12):9706-13.
Score: 0.006
-
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med (Berl). 1996 Aug; 74(8):455-62.
Score: 0.005